Duke Clinical Research Institute, Oxford Diabetes Trials Unit

• Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

  Collaborator, Recruiting, 270 people, 14 Aug 2024

• Evaluation of Ascorbate-Meglumine Therapeutic for SRS

  Collaborator, Phase 1, Status unknown, 12 people, 30 May 2024

• NCT06396858

  Phase 4, Not yet recruiting, 4,500 people, 2 May 2024

• NCT04746339

  Phase 4, Terminated, 411 people, 9 Feb 2021

• NCT04403685

  Collaborator, Phase 3, Terminated, 129 people, 27 May 2020

• NCT04142658

  Collaborator, Phase 3, Terminated, 863 people, 29 Oct 2019

• NCT02901184

  Collaborator, Phase 3, Recruiting, 2,000 people, 15 Sept 2016

• NCT02415400

  Collaborator, Phase 4, Completed, 4,614 people, 14 Apr 2015

• NCT02293395

  Collaborator, Phase 2, Completed, 3,037 people, 18 Nov 2014

• NCT00957242

  Collaborator, Phase 3, Terminated, 145 people, 12 Aug 2009

• NCT00831441

  Collaborator, Phase 3, Terminated, 7,484 people, 29 Jan 2009

• NCT00790205

  Collaborator, Phase 3, Completed, 14,671 people, 13 Nov 2008

Sources: clinicaltrials.gov

• Urinary Albumin-to-Creatinine Ratio and Risk of Incident Cardiovascular Disease in the KoGES-ARIRANG Community-Based Cohort

  1 Oct 2026

Sources: api.crossref.org